IL6 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), activated HSCs induce phenotypic changes in oncogenic hepatocytes, notably through the production of growth factors and cytokines such as HGF (hepatocyte growth factor) and IL6 in favor of tumor cell proliferation5.